Skip to main content
. 2018 Sep 14;1(4):141–154. doi: 10.1093/jcag/gwy047

Figure 1.

Figure 1.

Consensus guided algorithm for the management of patients with active perianal fistulizing CD. MTX, methotrexate; MAF, mucosal advancement flap.

*Medical therapy should be optimized, informed by therapeutic drug monitoring (if needed) before patients are considered refractory to treatment.